Latest Breaking News On - Rallybio corp - Page 1 : comparemela.com
Shares of Rallybio Corp. (RLYB) are up 71% on Thursday following the announcement of a partnership with Johnson & Johnson (JNJ) aimed at advancing therapeutic approaches to mitigate the risk of fetal and neonatal alloimmune thrombocytopenia also known as FNAIT.
NasdaqRallybio-corpJnjRallybioEnaitLyb